HALO
HALO
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
39
$72.30M
Total Volume
$72.30M
75 transactions
Net Activity
$72.30M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Torley Helen
Pres, CEO
$61.29M total
Posard Matthew L.
Dir
$2.61M total
Caudill Cortney
SVP, COO
$2.23M total
Labrosse Nicole
SVP, CFO
$1.69M total
Henderson Jeffrey William
Dir
$1.38M total
Quick Actions
HALO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at HALO (HALO) engaged in a total of 75 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 39 were sales. The total volume of insider trading reached $72.30M.
The net insider activity for HALO shows a net selling bias of $72.30M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Torley Helen (Pres, CEO), who traded 60.0K shares valued at $6.61M on Oct 6, 2026.
Halozyme Therapeutics, Inc. (HALO) Stock Price, News, Quote & History
HALO Rallies More Than 40% in 6 Months: How Should You Play the Stock?
HALO Stocks in Emerging Markets Could Extend Rally as Heavy Industries Surge
HALO Rallies More Than 40% in 6 Months: How Should You Play the Stock?
Halozyme’s president and CEO Helen Torley sells $6.0m in stock
Under a preset trading plan, a Halozyme (HALO) director sold 5,000 shares in two trades.
FAQs About HALO Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for HALO.